CABEI raises COVID-19 vaccine funding to $800m

The Central American Bank for Economic Integration (CABEI) has approved an increase of up to $400 million for the acquisition and application of vaccines against COVID-19 to eight countries.

With this new approval, CABEI increases the resources available to the countries of the Central American region to $800 million to finance the purchase of vaccines, as well as the financing of the logistics for their distribution and application to the population. The facility will provide each country with an allocation of $100 million.

In November 2020, CABEI became the first multilateral development bank to issue a COVID-19 Vaccine Bond and then a second bond in December 2020, both in the Asian market, to raise a total amount of $100 million from the capital markets.